Work

Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo

Year: 2008

Type: article

Study design: Clinical Trial

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2008.07.068

Authors: David Erlinge, Christoph Varenhorst, Oscar Ö. Braun, Stefan James, Kenneth J. Winters, Joseph A. Jakubowski, John T. Brandt, Atsuhiro Sugidachi, Agneta Siegbahn, Lars Wallentin

Institutions: Lund University, Uppsala University, Eli Lilly (United States), Daiichi-Sankyo (Japan)

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Eli Lilly and Company

OpenAlex ID: W1991372259

FWCI: 15.34

Cites: 33

Cited by: 211

Related to: 10